Insider Transactions in Q4 2021 at Cara Therapeutics, Inc. (CARA)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2021
|
Thomas Charles Reilly Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,170
+43.48%
|
-
|
|
Dec 17
2021
|
Scott Terrillion SEC'Y; CHIEF COMPLIANCE & G.C. |
BUY
Grant, award, or other acquisition
|
Direct |
11,495
+12.24%
|
-
|
|
Dec 17
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,607
+17.73%
|
-
|
|
Dec 17
2021
|
Frederique Ph.D. Menzaghi CHIEF SCIENTIFIC OFF,SVP-R&D |
BUY
Grant, award, or other acquisition
|
Direct |
12,607
+7.58%
|
-
|
|
Nov 12
2021
|
Jeffrey L. Ives |
SELL
Open market or private sale
|
Direct |
8,180
-53.19%
|
$130,880
$16.04 P/Share
|
|
Nov 01
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-2.13%
|
$17,000
$17.15 P/Share
|
|
Oct 29
2021
|
Christopher Posner PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
147,941
+33.82%
|
-
|
|
Oct 27
2021
|
Joana Goncalves CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,000
-2.09%
|
$15,000
$15.0 P/Share
|